Pharmacokinetics, Pharmacodynamics, & Drug Metabolism Community

 View Only
Back to discussions
Expand all | Collapse all

Speaker Spotlight: Extrapolating Efficacy from Adults to Pediatrics OCT 18 at 2:30 pm

  • 1.  Speaker Spotlight: Extrapolating Efficacy from Adults to Pediatrics OCT 18 at 2:30 pm

    Community Leadership
    Posted 10-12-2022 08:36
    Dear all,
     
    We will have one of the most experienced former FDA Pharmacometrician that will talk about adult data extrapolation to pediatric population.  If you are attending PharmSci360, set aside an hour to listen to him (which may save you many hours or refresh your knowledge on this subject). 

    This is an area to save money and time, if we know how to navigate regulatory expectations. Innovative regulatory science is one of the key components. 

    Highly recommend to communities that involve RS, PPDM, Pediatric, Modeling, and Pharmacometrics to attend this. 
    -Raja
    Vice Chair, RS community 

    Session Details:

    Oct 18 Tuesday

    2:30 PM – 3:30 PM ET

    Speaker Spotlight: Extrapolating Efficacy from Adults to Pediatrics


    Location:Spotlight Stage 2, Exhibit Hall A&B

    Spotlight Speaker: Joga Gobburu, PhD, MBA – University of Maryland

    Moderator: Raja B. Velagapudi, PhD – Tolmar, Inc.

    Clinical Pharmacology – Chemical



    ------------------------------
    Raja Velagapudi Ph.D.
    Sr. Director, Clinical Development
    Tolmar Inc
    Monmouth Junction NJ
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------


  • 2.  RE: Speaker Spotlight: Extrapolating Efficacy from Adults to Pediatrics OCT 18 at 2:30 pm

    Community Leadership
    Posted 10-13-2022 10:45
    Thanks Raja for this presentation notice!

    Yes, extrapolating adult clinical data to the pediatric population remains a huge challenge for drug discovery, development, and safety!

    I look forward to this talk and meeting old and new colleagues Face-to-Face for the first time since the beginning of the pandemic.

    Best regards,
    Steven-

    ------------------------------
    Steven Louie M.S.
    Sr. Principal Scientist
    Novartis
    Cambridge MA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------

    Original Message